Dr. Noecker

Pittsburgh, Pennsylvania 15213

0 studies enrolling now · 5 studies all time

What they study most

Glaucoma

Studies at this site

• Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004% — Completed
• Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost — Completed
• A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension — Completed
• Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost — Completed
• Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension — Completed